Description
+ Include: 36 videos + 32 pdfs, size: 14.5 GB
+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma
+ Sample video: contact me for sample video
+ Information:
Friday, April 26, 2024, 8:00 AM – Saturday, April 27, 2024, 2:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Join us for the 8th edition of the MSK Symposium on Lymphoma, where renowned international and national experts will provide a comprehensive update on the continually evolving landscape of lymphoma research. Explore the latest breakthroughs in lymphoma biology, cutting-edge diagnostics, and groundbreaking treatment strategies that are reshaping the future of patient care.
This year’s symposium will focus on the clinical management of the most prevalent lymphoma types, while also unveiling exciting developments in new drugs that promise to revolutionize treatment options. Faculty will present these innovations and engage in dynamic panel discussions on how to practically tailor patient care for the best outcomes. Furthermore, the program will include an impactful keynote lecture, exciting hot topics, and extensive networking opportunities, both during breaks and at the networking reception and concluding luncheon. Specifically for our interprofessional care team, a dedicated session on nursing professional development will be offered.
Don’t miss the opportunity to explore the latest advancements in lymphoma biology and pathology, understanding how these discoveries pave the way for innovative therapies. Join us in the exploration from scientific breakthroughs to solutions, alongside our distinguished faculty.
This symposium offers participants the choice of attending either in person at Memorial Sloan Kettering’s Zuckerman Research Center or virtually via Zoom. Exclusive sessions are available to those who attend in person.
Who Should Attend
The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.
- Describe recent refinements in lymphoma classification
- Discuss first line treatment options in the most frequent lymphoma entities
- Discuss options and recommendations for patients in the relapse refractory setting, including the integration of recently approved therapies
- Provide adequate information to help shared decision making with patients regarding their treatment
+ Topics:
Adolescent and Young Adult (AYA) Challenges.mp4
Adolescent and Young Adult (AYA) Challenges.pdf
Advances in Radiomics.mp4
Advances in Radiomics.pdf
ASCT or CAR T cells in CNSL..mp4
ASCT or CAR T cells in CNSL.pdf
Bispecific in DLBCL- When and How.mp4
Bispecific in DLBCL- When and How.pdf
Bispecific Therapy in Lymphoma- A Multidisciplinary Practice.mp4
Bispecific Therapy in Lymphoma- A Multidisciplinary Practice.pdf
Challenges in CAR T-cell Therapy.mp4
Challenges in CAR T-cell Therapy.pdf
Challenges in Older Patients.mp4
Challenges in Older Patients.pdf
Clinical Advances and Persisting Challenges.mp4
Clinical Advances and Persisting Challenges.pdf
Deciphering HL Biology.mp4
Deciphering HL Biology.pdf
DLBCL- Advances in 2024.mp4
DLBCL- Advances in 2024.pdf
DLBCL- Evolving Standards of Care and Navigating Complex Scenarios Panel Discussion.mp4
Epigenetic Profiling of T-cell Lymphoma.mp4
Epigenetic Profiling of T-cell Lymphoma.pdf
Evaluating AEs and Treatment Tolerability in Clinical Trials.mp4
Evaluating AEs and Treatment Tolerability in Clinical Trials.pdf
First Line Therapy.mp4
First Line Therapy.pdf
From Research to Patient Care- Optimizing the Role of Clinical Trials Nurses and Advanced Practice Providers.mp4
From Research to Patient Care- Optimizing the Role of Clinical Trials Nurses and Advanced Practice Providers.pdf
Hodgkin Lymphoma- Enhancing Treatment Efficacy and Minimizing Side Effects Panel Discussion.mp4
How to Facilitate Rapid Patient Access to MSK- The APP Lymphoma Diagnostic Program.mp4
How to Facilitate Rapid Patient Access to MSK- The APP Lymphoma Diagnostic Program.pdf
Lymphoma2024_Brochure.pdf
Mantle Cell Lymphoma.mp4
Mantle Cell Lymphoma.pdf
Marginal Zone Lymphoma.mp4
Marginal Zone Lymphoma.pdf
Molecular Pathways in FL.mp4
Molecular Pathways in FL.pdf
New Approaches.mp4
New Approaches.pdf
New drugs in Development.mp4
New drugs in Development.pdf
Optimizing Chronic Lymphocytic Leukemia Management- Harnessing New Agents for Improved Outcomes Panel Discussion.mp4
Optimizing Radiation in the Context of CAR T-cell Therapy.mp4
Optimizing Radiation in the Context of CAR T-cell Therapy.pdf
Pathological Insights and Contemporary Therapeutic Breakthroughs- Keeping Pace with Recent Advances Panel Discussion.mp4
Pathology of T-cell lymphoma _T-helper T-cell Lymphoma.mp4
Pathology of T-cell lymphoma _T-helper T-cell Lymphoma.pdf
Persisting Challenges and Open Questions in Primary and Secondary CNS Lymphoma Panel Discussion.mp4
Procedures in Hematologic Malignancy Evaluation and Treatment.mp4
Procedures in Hematologic Malignancy Evaluation and Treatment.pdf
Radiation Therapy in CNSL.mp4
Radiation Therapy in CNSL.pdf
Recent Advances in T-cell Lymphoma Therapy.mp4
Recent Advances in T-cell Lymphoma Therapy.pdf
Recent Advances.mp4
Recent Advances.pdf
Recent Insights in FL Classifications.mp4
Recent Insights in FL Classifications.pdf
Recent Insights in iNHL Classifications.mp4
Recent Insights in iNHL Classifications.pdf
Salvage Treatments.mp4
Salvage Treatments.pdf
Strategizing the Sequence of New Therapies in Follicular Lymphoma- A Guide to Optimizing Management Panel Discussion.mp4
The Evolving Standard of Care.mp4
The Evolving Standard of Care.pdf
Waldenstr”m Macroglobulinemia.pdf
Reviews
There are no reviews yet.